Document:

Second Amendment to the Asset Purchase Agreement

 Exhibit 10.40 
  
 Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4), 
 200.83 and 240.24b-2 
 SECOND AMENDMENT 
  
 This Second Amendment (“Amendment”), dated February 3, 2005 (the “Effective Date”), by and between Flextronics Sales and Marketing
(A-P) Ltd., a Mauritius corporation (“Buyer”), and Agilent Technologies, Inc., a Delaware corporation (“Seller”), amends that certain Asset Purchase Agreement, dated October 27, 2004, by and between the Buyer and Seller, as
amended by the First Amendment, dated January 4, 2005 (the “Agreement”). Terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement. 
  
 RECITALS 
  
 WHEREAS, both Parties desire to amend the terms and conditions of the Agreement in the manner set forth below; 
  
 NOW, THEREFORE, in consideration of the foregoing and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties do hereby agree as follows: 
  
 AGREEMENT 
  
 The Agreement shall be amended as follows: 
  
 1. The
definition of “Products” in Article 1 Definitions shall be amended and restated in its entirety as follows: 
  
 ““Products” means those set forth on Schedule 1.1(a) of this Agreement, as amended and restated and attached to the Second
Amendment.” 
  
 The amended and restated Schedule 1.1(a) is attached hereto.

  
 2. The reference in Section 2.1(a)(i) to “Section
2.1(d)” shall be deleted and replaced with “Section 2.3”. 
  
 3. The reference in Section 2.1(a)(ii) to “Section 2.1(e)” shall be deleted and replaced with “Section 2.3”. 
  

4. Section 2.1(a)(iii) shall be amended and restated in its entirety as follows: 
  
 “All rights of the Seller and its Subsidiaries under the Contracts set forth on Schedule 2.1(a)(iii).”

  
 5. Sections 2.1(d), 2.1(e) and 2.1(f) of the Agreement shall
be deleted in their entirety. 
  
 6. The Parties agree to delete
Section 2.2(a)(v) in its entirety and replace it with the following: 
  
 “(v) except for Liabilities that are not assumed under Assumed Contracts in (iv) above, the Liabilities under the [ * ] Agreement set forth on Schedule 2.2(a)(v)(i), and the amortization per unit for the [
* ] clean room while Buying Entities use such clean room as set forth on Schedule 2.2(a)(v)(ii), and are reflected in the agreement to be negotiated in accordance with Section 6.14 of this Agreement between the Buying Entities and [ *
];” 
  

 * Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. Omitted portions have been filed separately with the Commission. 

 Schedule 2.2(a)(v)(i) and Schedule 2.2(a)(v)(ii) are attached hereto. 
  
 7. The Parties agree to renumber Section 2.2(a)(vi) to Section 2.2(a)(vii)
and add the following new Section 2.2(a)(vi): 
  
 “(vi) the
Liabilities set forth on Schedule 2.2(a)(vi); and” 
  
 Schedule 2.2(a)(vi) is attached hereto. 
  
 8. The
Parties agree to delete Section 2.2(b)(x) in its entirety and replace it with the following: 
  
 “(x) the Liabilities under the [ * ] Agreement, except (1) the Liabilities under the [ * ] Agreement set forth on Schedule
2.2(a)(v)(i) and (2) the amortization per unit for the [ * ] clean room while Buying Entities use such clean room as set forth on Schedule 2.2(a)(v)(ii); provided, in any event, Seller retains all Liability for amortization per unit for
the [ * ] clean room, including as set forth on Schedule 2.2(a)(v)(ii), upon and after Buying Entities’ discontinued use of such clean room;” 
  

9. The Parties agree to renumber Section 2.2(b)(xi) to Section 2.2(b)(xii) and add the following new Section 2.2(b)(xi): 
  
 “(xi) any Liability related to Inventory or Product referenced in
Section 9.4(a)(iv) that is ordered, purchased or sold by Seller.” 
  
 10. A new Section 2.3 shall be added to the Agreement, as follows: 
  
 “2.3 Section 2 Schedules Update. 
  
 (a) The Buyer and Seller agree that Schedule 2.1(a)(i) attached hereto is the updated Schedule 2.1(a)(i), Schedule 2.1(a)(ii) attached hereto is the updated Schedule 2.1(a)(ii), Schedule
2.1(a)(iii) hereto is the updated Schedule 2.1(a)(iii), all of which may be updated only in accordance with Section 2.3(b) below.  
  
 (b) Within fifteen (15) business days after the Closing, Seller shall propose updates to Schedule 2.1(a)(i), Schedule
2.1(a)(ii), Schedule 2.1(a)(iii), Schedule 2.2(a)(v)(i), Schedule 2.2(a)(v)(ii) and Schedule 2.2(a)(vi) as of the Closing Date which may be updated for additions and deletions of assets and Liabilities designated
specifically for the Products and added or deleted in the Ordinary Course of Business 
  

 * Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. Omitted portions have been filed separately with the Commission. 

 between the date of the updated Schedules agreed upon in accordance with Section 2.3(a) and the Closing
Date. Buyer reserves the right to reject any proposed updates provided hereunder in its reasonable business judgment; provided, however, that Buyer may not reject (A) any Inventory added to Schedule 2.1(a)(i) or Fixed Assets added to
Schedule 2.1(a)(ii) that was previously on a Schedule 2.1(a)(iii), Schedule 2.2(a)(v)(i) and Schedule 2.2(a)(vi) and only to the extent deleted therefrom and (B) any changes to Schedule 2.1(a)(i) for increases less
than $50,000 for each part number. The Parties shall agree on changes to the schedule, if any, within ten (10) business days after the delivery of such schedule. 
  
 11. The reference to “$12,000,000.00” in the first sentence of Section 3.1 shall be changed to
“$12,516,000.00”. 
  
 12. The Parties agree to add
“plus the other amounts set forth in Section 3.6(b)(iii)” to the end to the end of Section 3.1(b). 
  
 13. The references to “December 31, 2005” in Section 3.1(c) shall be changed to “January 31, 2006”. 
  
 14. Section 3.3(a) shall be in the following manner: 
  
 a. the reference to “October 31, 2005” shall be changed to
“January 31, 2006”; 
  
 b. the reference to
“November 1, 2005” shall be changed to “February 1, 2006”; 
  
 c. the reference to “October 31, 2006” shall be changed to “January 31, 2007”; 
  
 d. the reference to “November 1, 2006” shall be changed to “February 1, 2007”; and 
  
 e. the reference to “October 31, 2007” shall be changed to
“January 31, 2008”. 
  
 15. The Parties agree to delete
Section 3.2(a) in its entirety and replace it with the following: 
  
 “(a) Within thirty (30) days following Closing, a Representative of the Buyer and a Representative of the Seller shall calculate the amount of the Net Book Value of the Purchased Inventory and the Fixed Assets as
of the Closing which shall be prepared in accordance with GAAP and on a basis consistent with the Net Book Value of Purchased Inventory and Fixed Assets as of the last day of the month immediately preceding the Closing Date (the “Closing
Statement”). Promptly after completing the Closing Statement, the Representatives shall deliver the Closing Statement to the Parties for their review and approval within seven (7) days of delivery. If either Party does not provide written
notice of any objection to the Net Book Value of the Purchased Inventory and the Fixed Assets set forth in the Closing Statement within such 7-day period, such Party shall be deemed to accept the Closing Statement. If the Representatives (during
their 30-day period) or Parties (within their 7-day period) have provided a written objection or otherwise do not agree on Net Book Value set forth in the Closing Statement, the Parties shall attempt to resolve their differences with respect thereto
within thirty (30) days after either Party provides written notice of their disagreement. Any disputes not resolved within such thirty (30) day period regarding the Closing Statement shall be resolved by a 

 major accounting firm jointly selected by Seller and Buyer and with no prior or current service to either
Buyer or Seller (the “Firm”). The Firm shall make a determination in accordance with this Agreement on the disputes so submitted as well as such modifications, if any, to the Closing Statement as reflect such determination, and the
same shall be conclusive and binding upon the Parties. The determination of the Firm for any item in dispute cannot, however, be in excess of, nor less than, the greatest or lowest value, respectively, claimed by the Parties for that particular item
in the Closing Statement. The Seller shall bear and pay 50% of the fees and other amounts payable in connection with the foregoing, and the Buyer shall bear and pay the remaining 50% of such fees and other amounts.” 
  
 16. A new Section 3.3(g) shall be added as follows: 
  
 “(g) Notwithstanding the foregoing, if after Buyer has
used commercially reasonable efforts to consume the Purchased Inventory set forth on Schedule 3.3(g)(i), the Purchased Inventory set forth on Schedule 3.3(g)(ii) and to procure cancellation or forgiveness of the [ * ]Liability set
forth on Schedule Schedule 3.3(g)(iii) from such third parties (as opposed to Buyer’s payment or other provision of consideration for such Liability), to the extent such Purchased Inventory has not been consumed and to the extent such [
* ] Liability has not been cancelled or forgiven by January 31, 2006, then Buyer shall be entitled to reduce and offset the unconsumed Purchased Inventory set forth and at the value designated on Schedule 3.3(g)(i) but only up to $2,000,000,
the unconsumed Purchased Inventory set forth and at the value designated on Schedule 3.3(g)(ii) but only up to $900,000 and the uncancelled or unforgiven amount of the [ * ] Liability but only up to $500,000 against the Year 1 Contingent
Consideration and the Year 2 Contingent Consideration to which Seller becomes entitled hereunder.” 
  
 17. The Parties agree to delete Section 3.6(b)(iii) in its entirety and replace it with the following: 
  
 “(iii) the Buying Entities designated by Buyer shall
pay to the Selling Entities designated by Seller an amount equal to (i) the Estimated Fixed Assets Value in cash or by wire transfer as contemplated by Section 3.1 plus (2) $7,383.61 for the Mollusk Sample build, 500 kits sent January
4, 2005 and the Doumen V56 setup plus (3) $516,000 of the cash portion of the Purchase Price minus (4) the amount of vacation pay assumed by the Buyer Parent and/or any of its Subsidiaries pursuant to Section 6.8.”

  
 18. The Parties agree to delete Section 6.8(b) in its entirety
and replace it with the following: 
  
 “(b)
Payment of Severance Pay. Each Selling Entity shall make payment in full to all Transferred Employees of all severance pay, bonuses, other accrued employment benefit payments on or before the due date for such payment under applicable Laws,
and otherwise in a manner in accordance with applicable Laws. If Buyer Parent and/or any of its Subsidiaries are required to assume any of these amounts, such amount assumed shall be reimbursed by Seller or may be a Purchase Price 
  

 * Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. Omitted portions have been filed separately with the Commission. 

 adjustment or offset at Buyer’s discretion. Notwithstanding the foregoing, the amount set forth in
Schedule 6.8(c) shall be assumed by Buyer Parent or any of its Subsidiaries, shall be offset against the portion of the Purchase Price due at Closing in accordance with Section 3.6, and shall not be subject to reimbursement from Seller.”

  
 Schedule 6.8(c) is attached hereto. 
  
 19. The Parties agree to delete Section 6.8(c) in its entirety and replace it
with the following: 
  
 “(c) Employee
Liabilities. Except for Employee Assumed Liabilities (defined below), the Seller and its Subsidiaries shall be responsible for any Liabilities related to their employees that have accrued prior to the Closing Date, including, but not limited to,
any Liabilities associated with the seniority of employees who will become Transferred Employees. For the avoidance of doubt, the Buyer Parent and its Subsidiaries shall not assume, and the Seller and its Subsidiaries shall retain as Liabilities any
unpaid salary, accrued severance pay, allowances, bonuses and any other remuneration or monetary benefits, and any other obligations owed to the employees of the Seller and its Subsidiaries, arising from or in connection with their employment by the
Seller and its Subsidiaries or any current or former Affiliate of the Seller and its Subsidiaries. The following liabilities with respect to the Transferred Employees will be considered “Employee Assumed Liabilities”: (i) any pre-closing
Liability relating to a Transferred Employee that the Buyer Parent and the relevant Subsidiary is required strictly by Law to assume (and not as a result of violation of Law or other contractual or Benefit Plan obligation by Seller) and (ii)
vacation pay of the Transferred Employees as set forth on Schedule 6.8(c) and assumed by Buyer Parent and/or any of its Subsidiaries in accordance Section 6.8(b). In addition, the Buyer Parent and its Subsidiaries will recognize the
Transferred Employee’s term of service with the Seller and its Subsidiaries for the purpose of calculating the eligibility for short term disability benefits under Buyer Parent and its Subsidiaries’ employee Benefit Plans as well as
vacation and paid time accrual.” 
  
 20. The Parties agree to
delete Section 6.12(b) in its entirety and replace it with the following: 
  
 “(b) If Seller requests, the Buyer shall, and shall cause its Affiliates to, sell Products to Seller or its Subsidiaries at [ * ] of the price the Product is to be purchased by the customer(s) under for the
shortest period necessary after Closing to enable Seller or its Affiliates to meet its minimum obligations under any Assumed Contract or obligation of Seller which requires the delivery of Products but which has not yet been transferred to a Buying
Entity despite each Party’s commercially reasonable efforts to obtain such Consents pursuant to Section 6.3 of this Agreement or terminated; provided, however, the foregoing shall not apply to any Assumed Contract under which Seller has not
received Consent to transfer to Buyer, but with respect to which Buyer or any of its Subsidiaries have entered into a contract or accepted a purchase order with the applicable third party that such third party confirms in writing is intended to
replace such Assumed Contract. 
  

 * Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. Omitted portions have been filed separately with the Commission. 

 Seller and Buyer agree to and agree to cause their respective Subsidiaries and Affiliates to cooperate in
good faith with each other in communicating the cancellation and rebooking of purchase orders. Without limiting the foregoing, if Seller or any of its Subsidiaries reasonably requests an update of the purchase orders rebooked with Buyer and its
Affiliates or if Buyer or any of its Affiliates reasonably requests an update of the purchase orders cancelled with Seller and its Subsidiaries, Buyer and its Affiliates and Seller and its Subsidiaries, as the case may be, will provide such updates
in a timely manner.” 
  
 21. The Parties agree to amend
Section 6.12(c) by adding the following to the end of the Section: 
  
 “To the extent Seller terminates any Assumed Contract in accordance with the foregoing, Seller shall retain all Liability in connection with such termination.” 
  
 22. The Parties agree to amend and restate Section 7.2 in its entirety as
follows: 
  
 “7.2 Consents and
Approvals. All required board of director and stockholder approvals, if necessary, of the Selling Entities shall have been obtained, and written evidence of the same shall be provided to Buyer.” 
  
 23. The Parties agree to delete Section 9.4 in its entirety and replace it
with the following: 
  
 “(a) For a period of
[ * ] following the Closing Date (“Non-Compete Period”), the Seller shall not, and the Seller shall cause its Subsidiaries not to, without the prior written consent of the Buyer, directly or indirectly, own, manage, control, participate
in, or in any manner engage in the business of developing, distributing, manufacturing, selling and marketing Camera Module products that are configured and intended for inclusion in a personal, portable, handheld device for human voice
communication over a cellular network (a “Competitive Activity”) within any Restricted Territory; provided, however, that notwithstanding the foregoing, the Seller and its Subsidiaries shall be able to engage in the following activities:
(i) the acquisition or ownership of securities of no more than five percent (5%) of the outstanding voting power of any competitor which are listed on any national securities exchange or traded in the national over-the-counter market; (ii) the
acquisition, merger or any other business combination with or investments in any Person whose primary business is not a Competitive Activity so long as after such acquisition, the Seller and its Subsidiaries shall not engage in the Competitive
Activity; (iii) existing or future licenses or other dispositions of Agilent Intellectual Property so long as such licenses and dispositions are in accordance with Section 2.12 of the License Agreement; (iv) Seller’s actions under Contracts
pursuant to Section 6.12 hereof, until such Contracts can be transferred to the Buying Entities or terminated; (v) actions taken pursuant to the Transaction Agreements; and (vi) the distribution, sale and marketing of any Inventory listed on any
Schedule 2.1(a)(i) delivered by the Seller that is not on the definitive Schedule 2.1(a)(i), and therefore, not transferred to the Buyer as Purchased Inventory and the Inventory required to be 
  

 * Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. Omitted portions have been filed separately with the Commission. 

 purchased by Seller and its Subsidiaries pursuant to Contracts or Liabilities not assumed by the Buying
Entities. For the avoidance of doubt, the Parties agree that this Section 9.4 shall not in any way limit the Seller and its Subsidiaries from engaging in the business of developing, distributing, manufacturing, selling and marketing of Image
Sensors. As used in this Agreement, “Restricted Territory” means the areas in the world in which any Buyer’s Parent or its Affiliates are doing business.” 
  
 24. The Parties agree that Section 10.1(a) of the Agreement shall be deleted and replaced in its entirety with the
following: 
  
 “(a) by either Party if the
Closing shall not have occurred by one hundred and twenty (120) days from the date hereof; provided, however, that the right to terminate this Agreement under this Section 10.1(a) shall not be available to any Party whose failure to fulfill
any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date;” 
  

25. The Parties agree that the Closing shall take place at 4:00 p.m. PST on February 3, 2005. 
  
 26. This Amendment shall be governed by the laws of the State of California.
Except for the amendment stated above, no other provision of the Agreement is amended and it shall remain in full force and effect. 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their duly authorized
officers or representatives as of the Effective Date. 
  

			
	FLEXTRONICS SALES & MARKETING (A-P) LTD.
		
	By:	 	 /s/ Manny Marimuthu

		
	Name:	 	 Manny Marimuthu

		
	Title:	 	 Director

	
	AGILENT TECHNOLOGIES, INC.
		
	By:	 	 /s/ Young Sohn

	Name:	 	Young Sohn
	Title:	 	President, Semiconductor Products GroupConsent, Waiver and Amendment to Third-Lien Loan and Guaranty Agreement

 Exhibit 10.23(b) 
 EXECUTION VERSION 
  
 CONSENT, WAIVER AND AMENDMENT TO 
 THIRD-LIEN LOAN AND GUARANTY AGREEMENT 
  
 This CONSENT AND AMENDMENT, dated as of May 24, 2005 (this
“Amendment”), to the Third-Lien Loan & Guaranty Agreement, dated as of April 13, 2005 (the “Agreement”) by and among RELIANT PHARMACEUTICALS, INC., a corporation organized under the laws of the state of Delaware
(“Company”), CERTAIN SUBSIDIARIES OF COMPANY, as Guarantor Subsidiaries, the Lenders party thereto from time to time, and GOLDMAN SACHS CREDIT PARTNERS L.P. (“GSCP”) as Administrative Agent and
Collateral Agent, is by and among the Company, GSCP, the Requisite Lenders signatory hereto and FIRST SOURCE FINANCIAL, INC. as successor administrative agent and successor collateral agent (“First Source”). Capitalized terms
used and not defined herein shall have the meanings ascribed thereto in the Agreement. 
  
 WHEREAS, GSCP desires to resign as Administrative Agent and Collateral Agent and First Source has agreed to succeed GSCP as Administrative Agent and Collateral Agent under the Agreement and under the Credit Documents;

  
 WHEREAS, the Company, GSCP and First Source desire to amend
certain provisions of the Agreement relating to the succession of the Administrative Agent and Collateral Agent and as requested by First Source; 
  
 WHEREAS, the consent of the Requisite Lenders is required under Section 10.5 of the Agreement to approve the appointment of First Source as Administrative
Agent and to amend the Agreement; and 
  
 NOW, THEREFORE, the
Company, Lenders, GSCP and First Source agree to amend the Agreement as follows: 
  
 ARTICLE ONE 
  
 AMENDMENTS OF
AGREEMENT 
  
 Section 1.01. Amendment to “Pro Rata Shares;
Availability of Funds.” 
  
 (a) Section 2.5(a) of the
Agreement is hereby amended by inserting “or Administrative Agent” after the existing language that reads “it being understood that no Lender”. 
  
 (b) The clause within Section 2.5(b) of the Agreement that reads, “Administrative Agent may assume that such Lender has
made such amount available to Administrative Agent on such Credit Date, or Administrative Agent shall make available to Company a corresponding amount on such Credit Date” is hereby amended by replacing “shall” with “may, in its
sole discretion,”. 
  
 Section 1.02 Amendment to
“General Provisions Regarding Payments.” Section 2.16(h) is hereby amended by deleting the first paragraph in its entirety and replacing it with the following: 
  
 “If an Event of Default shall have occurred and not otherwise been waived, and the maturity of the Obligations shall
have been accelerated pursuant to Section 8.1, all payments or proceeds received by Agents hereunder in respect of any of the Obligations, shall be applied first, to the payment of all reasonable costs and expenses of such sale, collection or
other realization, including reasonable compensation to the Collateral Agent 

  

 1 

 
and Administrative Agent and their agents and counsel, and all other reasonable expenses, liabilities and advances made or incurred by the Administrative
Agent and Collateral Agent in connection therewith, and all amounts for which the Collateral Agent and Administrative Agent are entitled to indemnification hereunder (in their capacity as the Collateral Agent or Administrative Agent and not as a
Lender) and all advances made by the Collateral Agent and Administrative Agent hereunder for the account of the applicable Grantor, and to the payment of all costs and expenses paid or incurred by the Collateral Agent and Administrative Agent (in
their capacity as the Collateral Agent or Administrative Agent and not as a Lender) in connection with the exercise of any right or remedy hereunder or under the Credit Agreement, all in accordance with the terms hereof or thereof; second, to
the extent of any excess of such proceeds, to the payment of all other Obligations for the ratable benefit of the Lenders; and third, to the extent of any excess of such proceeds, to the payment to, or upon the order of, Company or Guarantor
Subsidiary or to whosoever may be lawfully entitled to receive the same or as a court of competent jurisdiction may direct.” 
  
 Section 1.03 Amendment to “Powers and Duties”. Section 9.2 of the Agreement is hereby amended by inserting the following sentence at the
end of such Section: “No Agent shall be required to take any action that, in its opinion or the opinion of its counsel, may expose such Agent to liability (except with respect to obligations of such Agent expressly set forth in the Credit
Documents for which it has received indemnification in accordance with the provisions of Section 9.6) or that is contrary to any Credit Document or applicable law.” 
  
 Section 1.04 Amendment to “General Immunity.” 
  
 (a) Section 9.3(a) of the Agreement is hereby amended by inserting the
following sentence at the end of such subsection (a): “No Agent shall be required to take any action that, in its opinion or the opinion of its counsel, may expose such Agent to liability (except with respect to obligations of such Agent
expressly set forth in the Credit Documents for which it has received indemnification in accordance with the provisions of Section 9.6) or that is contrary to any Credit Document or applicable law.” 
  
 (b) Section 9.3(b) of the Agreement is hereby amended by inserting “as
determined by a court of competent jurisdiction by a final and nonappealable judgment” at the end of the first sentence before the period in such subsection (b). 
  
 Section 1.05 Amendment to “Right to Indemnity.” Section 9.6 of the Agreement is hereby amended by inserting
“as determined by a court of competent jurisdiction by a final and nonappealable judgment” at the end of the first proviso after “gross negligence or willful misconduct” and before the period in such proviso. 
  
 Section 1.06 Amendment to Successor Administrative Agent.  

 
 (a) Section 9.7 of the Agreement is hereby amended by inserting “and
Sections10.2 and 10.3” after “the provision of this Section 9” in the final sentence of Section 9.7. 
  
 (b) Section 9.7 of the Agreement is hereby further amended by inserting the following after the second sentence of such Section: 
  
 “If no such successor shall have been so appointed by the Requisite
Lenders and shall have accepted such appointment within 30 days after the retiring Administrative Agent 

  

 2 

 
gives notice of its resignation or is removed, then the retiring Administrative Agent may, on behalf of the Lenders, appoint a successor Administrative Agent
meeting the qualifications set forth above; provided, that if the Administrative Agent shall notify the Borrower and the Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become
effective in accordance with such notice and (1) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Credit Documents (except that in the case of any collateral security held by the
Administrative Agent on behalf of the Lenders or the Agents under any of the Credit Documents, the retiring Administrative Agent shall continue to hold such collateral security until such time as a successor Administrative Agent is appointed) and
(2) all payments, communications and determinations provided to, or made by, or through the Administrative Agent shall instead be made by or to each Lender, until such time as the Requisite Lenders appoint a successor Administrative Agent as
provided for above in this paragraph.” 
  
 Section 1.07.
Amendment to “Collateral Documents and Guaranty. Section 9.8 of the Agreement is hereby amended by inserting the following after the final sentence of such Section: 
  
 “Administrative Agent or Collateral Agent, as applicable, may execute any documents or instruments necessary to (a)
release any Lien encumbering any item of Collateral (i) upon payment in full of all Obligations (other than contingent indemnification obligations to the extent no claim giving rise thereto has been asserted) or (b) to subordinate its interest in
any Collateral to any holder of a Lien on such Collateral which is permitted by clause (l) or (m) of Section 6.2 (it being understood that Administrative Agent and Collateral Agent may conclusively rely on a certificate from Borrower in
determining whether the Debt secured by any such Lien is permitted by Section 6.1(k)). Upon request by Administrative Agent or Collateral Agent at any time, Lenders will confirm in writing Administrative Agent’s or Collateral
Agent’s authority to release, or subordinate its interest in, particular types or items of Collateral pursuant to this Section 9.8.” 
  
 Section 1.08 Amendment to “Amendments and Waivers”. Section 10.5(c) of the Agreement is hereby amended by inserting “or in any other
Credit Document” after the language “or any other provision hereof”. 
  
 Section 1.09 Amendment to Lender Name. All references to “PG Gigi M Trust” in the Agreement and related schedules are hereby amended and changed to “P.G. Gigi Trust M”. 
  
 ARTICLE TWO 
  
 CHANGE OF ADMINISTRATIVE AGENT 
  
 Section 2.01. Waiver of Notice. The Lenders signatory hereto comprising the Requisite Lenders hereby waive the requirement under Section 9.7 of the
Agreement to provide five day’s notice prior to the effectiveness of any resignation by GSCP as Administrative Agent. 
  
 Section 2.02. Resignation of Current Administrative Agent. Having given the requisite notice of resignation pursuant to Section 9.7 of the
Agreement, GSCP hereby resigns as the Administrative Agent under the Agreement, and the Company and the Lenders signatory hereto comprising the Requisite Lenders hereby accept such resignation, to be effective as of May 24, 2005 (the “Effective
Date”). 
  

 3 

 Section 2.03 Appointment of Successor Administrative Agent. The Lenders signatory hereto
comprising the Requisite Lenders hereby consent to, and appoint First Source as Administrative Agent under the Agreement, and First Source hereby accepts such appointment. Each Lender hereby authorizes First Source to act as its Administrative Agent
in accordance with the terms of the Agreement and the other Credit Documents. The appointment and succession of First Source as Administrative Agent shall be effective as of the Effective Date. 
  
 Section 2.04 Transfer of Rights and Responsibilities. 
  
 (a) GSCP hereby confirms, assigns, transfers, delivers and conveys, without
recourse, as of the Effective Date, to First Source as successor Administrative Agent under the Agreement, all rights, powers, privileges, duties and obligations that GSCP, as the resigning Administrative Agent now holds under and by virtue of the
Agreement. 
  
 (b) Each of GSCP and Company hereby agree to take,
upon the reasonable request of First Source and at the reasonable expense of the Company, such additional actions and to execute and deliver such other documents and instruments to effect First Source’s succession as Administrative Agent under
the Agreement and the other Credit Documents. 
  
 ARTICLE THREE

  
 MISCELLANEOUS PROVISIONS 
  
 Section 3.01. Continuing Effect. Except as expressly amended by this
Amendment, the Agreement remains in full force and effect in accordance with its terms and is hereby in all respects ratified and confirmed. 
  
 Section 3.02. References to the Agreement. All references to the Agreement in Credit Documents, or in any other document executed or delivered in
connection therewith, shall, from the date hereof, be deemed a reference to the Agreement as amended hereby, unless the context requires otherwise. 
  
 Section 3.03. Notices. All notices or deliveries to be given or made to First Source under the Agreement or any other Credit Document shall be to
the following: 
  

	
	First Source Financial, Inc.
	Jeffrey A. Cerny
	Executive Vice President
	2850 West Golf Road
	Suite 520
	Rolling Meadows, IL 60008
	Tel.
	Fax.

  
 Section 3.04,
Governing Law. This Amendment shall be governed by and construed in accordance with the law governing the Agreement. 
  
 Section 3.05. Counterparts. This Amendment may be executed in any number of counterparts, each of which shall for all purposes be deemed to
be an original and all of which together shall constitute one and the same document. 
  
 [SIGNATURE PAGE FOLLOWS] 
  

 4 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their respective officers thereunto duly
authorized as of the date first written above. 
  

			
	RELIANT PHARMACEUTICALS, INC.
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 
	
	RP SUB NO. 1, INC.,
	 as a Guarantor Subsidiary

		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 
	
	GOLDMAN SACHS CREDIT PARTNERS L.P.,
	 as Administrative Agent and Collateral Agent

		
	 By:
	 	  

	 	 	 Authorized Signatory

	
	FIRST SOURCE FINANCIAL, INC.,
	 as successor Administrative Agent and
 Collateral Agent

		
	 By:
	 	  

	 	 	 Authorized Signatory

  

 5 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

					
	BAY CITY CAPITAL FUND II, L.P., as Lender
		
	 By:
	 	 BAY CITY CAPITAL MANAGEMENT
 II, LLC, its manager

			
	 	 	 By:
	 	  

	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 6 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

					
	BAY CITY CAPITAL FUND III, L.P., as Lender
		
	 By:
	 	 BAY CITY CAPITAL MANAGEMENT
 III, LLC, its manager

			
	 	 	 By:
	 	  

	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 7 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

	
	  

	 Stephen Bowen, as Lender

  

 8 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	CRAVES FAMILY, L.L.C., as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 9 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	HANDELSMAN FAMILY INVESTMENT
	GROUP, LLC, as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 10 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	THE HEATHER ROAD TRUST, as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 11 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	 INTERNATIONAL CAPITAL GROUP S.A,
 as Lender

		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 12 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

	
	  

	 John J. Mack, as Lender

  

 13 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

	
	  

	 Ernest Mario, as Lender

  

 14 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	PHARMBAY INVESTORS, L.L.C., as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 15 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	PROMERICA CAPITAL, LLC, as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 16 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

	
	JAMES C. SMITH AND NORMA I.
	SMITH, JTWROS, as Lender
	
	  

	 James C. Smith:

	
	  

	 Norma I. Smith

  

 17 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

	
	  

	 Robert K. Steel, as Lender

  

 18 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	P.G. GIGI TRUST M, as Lender
		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

  

 19 

 Consent, Waiver and Amendment to 
 Third-Lien Loan & Guaranty Agreement 
  

			
	THE WEXNER CHILDREN’S TRUST II, as Lender
		
	 By:
	 	  

	 	 	 Jeffrey Epstein, not individually but solely
 in his capacity as trustee of the Trust.

  

 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]